Types of Radiation Therapy: How Each One Works and When It Is Used

The first thing many people notice in a radiation treatment room is how quiet it is. There is a wide table, a machine the size of a small car that swivels around it, a soft mechanical hum, and then nothing. No sensation of heat, no sting, no smell. Fifteen minutes later the patient stands up, collects a parking ticket and drives to work.

That ordinariness hides an extraordinary amount of engineering. Behind the hum sits a set of decisions about which of several radiation types fits a particular tumor, how sharply the beam should be shaped, and whether the source should sit outside the body, inside it, or circulate through the bloodstream.

Search results tend to list these options like a menu. This guide does something different: it explains what each type actually does at the level of cells and beams, where the evidence is firm, where it is still forming, and how oncology teams decide which tool to reach for.

What is the most common type of radiation therapy?

External beam radiation therapy is by a wide margin the most frequently used form. The National Cancer Institute describes it as the standard approach for most cancers treated with radiation, and it estimates that about half of all people diagnosed with cancer receive radiation of some kind during their care.

The reason is practical. A linear accelerator, the machine that produces the beam, can treat almost any part of the body without surgery, sedation or a hospital stay. Beams can be shaped, angled and repeated daily with millimeter precision. Nothing radioactive stays in the body, so a person is not a risk to family members afterward.

Within this single category sit several sub-types that differ mainly in how tightly the beam is sculpted and how it is guided: three-dimensional conformal radiation, intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), stereotactic techniques, and particle therapy using protons. Think of them as generations of the same tool rather than rival treatments. Each newer generation trades a little complexity for a smaller margin of healthy tissue caught in the beam.

Brachytherapy and systemic radiation fill the remaining space. They are less common overall but dominant for specific situations, such as certain gynecologic and prostate cancers or some thyroid cancers, where getting the radiation inside the body outperforms firing it in from outside.

How does radiation therapy actually kill cancer cells?

Every type of radiation therapy relies on the same underlying event: ionizing radiation strips electrons from atoms inside a cell, and the resulting chemical chaos breaks strands of DNA. A cell with lightly damaged DNA can repair itself. A cell with many double-strand breaks either dies outright or fails when it next tries to divide.

Cancer cells are especially vulnerable for two reasons the National Cancer Institute spells out. They divide more often than most normal cells, so they hit the moment of failure sooner. And many have already lost the repair machinery that healthy cells use to patch DNA, which is part of what made them cancerous in the first place.

That asymmetry is the whole strategy. Healthy tissue in the beam path is damaged too, but it recovers between sessions more effectively than the tumor does. Splitting the total treatment into daily sessions, a practice called fractionation, gives normal cells that recovery window while denying it to the cancer. It is why a course of external beam radiation is typically spread over weeks rather than delivered in a single afternoon, according to NHS patient guidance.

Two details often surprise people. Radiation keeps working after the last session, because damaged cells die over days to weeks as they attempt to divide, so scans are usually scheduled well after treatment ends. And the beam itself causes no pain during delivery; side effects arise later from the tissue response, not from the moment of exposure.

External beam radiation: what happens in the room

Treatment begins before the first beam is switched on. At a planning visit, often called simulation, the person lies on a CT scanner in the exact position they will use each day. Custom cushions or a lightweight mesh mask hold that position. Small skin marks or tiny permanent dots act as alignment references. The Mayo Clinic notes that this mapping step is what allows the team to aim precisely and reproducibly at the tumor while sparing surrounding organs.

Physicists and dosimetrists then build a plan on the scan, choosing beam angles and shapes so the radiation converges on the target from several directions. Any single beam is weak enough to spare the tissue it passes through; where the beams overlap, the effect stacks up.

The daily routine is brief. The Mayo Clinic describes sessions as generally lasting about 10 to 30 minutes, most of which is spent positioning, with the beam itself on for only a few minutes. The machine may rotate around the table. The therapists watch from an adjoining room on camera and intercom.

Courses vary widely. Some palliative treatments are a single visit; curative courses for many cancers run on weekdays for several weeks, as the NHS radiotherapy guide outlines. Fatigue and skin changes in the treated area are the most common effects, and they build gradually rather than appearing after one session.

3D-conformal, IMRT and VMAT: what the acronyms really change

The alphabet soup of external beam radiation describes one thing: how closely the high-dose region hugs the tumor’s shape.

Three-dimensional conformal radiation therapy uses the planning CT to design beams whose outline matches the tumor’s silhouette from each angle. Metal leaves inside the machine head slide in and out to block the corners. It was a major advance over older two-dimensional planning, which relied on flat X-ray films.

Intensity-modulated radiation therapy takes the same beams and varies their strength across the field. The metal leaves move during delivery, so one part of a beam can be strong where the tumor is thick and weak where it passes near the spinal cord or a salivary gland. The National Cancer Institute lists IMRT as a standard modern technique precisely because it can wrap a high dose around concave shapes, something a uniform beam cannot do.

Volumetric modulated arc therapy is IMRT delivered while the machine rotates continuously around the body, which typically shortens each session.

Image-guided radiation therapy adds a check step: low-dose imaging taken on the treatment table just before the beam fires, so the plan can be aligned to where the tumor actually sits that day. Organs shift with breathing, bladder filling and weight change over a multi-week course, and IGRT is how teams account for that drift.

The evidence supports these refinements mainly through reduced side effects rather than higher cure rates. Sparing the salivary glands in head and neck cancer, for instance, lowers the risk of permanent dry mouth, a benefit consistently noted in clinical guidance.

Stereotactic radiosurgery and SBRT: fewer visits, sharper focus

The word surgery in stereotactic radiosurgery misleads almost everyone. There is no incision. The name refers to the precision, which rivals a scalpel, and to the outcome, which is the destruction of a small target in one to a handful of sessions.

Stereotactic radiosurgery (SRS) is the term used for the brain and spine. Stereotactic body radiation therapy (SBRT), sometimes called SABR, applies the same idea to the lung, liver, pancreas, prostate and bone. Both deliver a much larger amount of radiation per session than conventional courses, made possible by extremely steep fall-off at the edge of the target. The Mayo Clinic describes these approaches as suited to small, well-defined tumors that imaging can locate exactly.

Precision comes from a combination of rigid immobilization, sometimes a frame or a tight mask, dozens of converging beam angles, and image guidance immediately before and even during delivery. Some systems track breathing so the beam pauses when a lung tumor moves out of position.

Where it is used: small brain metastases, certain benign brain lesions, early-stage lung cancer in people who cannot safely have surgery, and isolated spots of cancer that have spread to a limited number of sites. The National Cancer Institute notes it is generally not appropriate for large or diffuse tumors, where the tissue volume receiving a high dose would be unacceptable.

For patients, the appeal is obvious: a week of visits instead of six or seven. The trade-off is that eligibility is narrow and depends heavily on tumor size, location and the quality of the imaging available.

Proton therapy: is it better than X-rays?

Standard external beam radiation uses photons, which are high-energy X-rays. Photons deposit energy along their entire path, entering the body, passing through the tumor, and continuing out the far side into healthy tissue. Protons behave differently. As Johns Hopkins Medicine explains, a proton beam releases most of its energy at a set depth and then stops, with little or no exit dose beyond the target.

That physics is the entire argument for proton therapy. Where a critical structure sits directly behind a tumor, such as the brainstem in a child’s skull-base cancer, the heart behind a left-sided breast tumor, or the spinal cord behind a spinal tumor, a beam that stops short is attractive.

What the evidence actually shows is more measured than the marketing sometimes implies. For pediatric cancers, reducing radiation to developing tissue has a clear rationale, and proton therapy is widely used. For many common adult cancers, comparative trials are ongoing, and mainstream guidance treats protons as one option whose advantage in outcomes has not been consistently demonstrated over well-planned photon IMRT. Johns Hopkins Medicine frames the benefit primarily as reduced exposure to surrounding healthy tissue rather than higher tumor control.

Practical realities matter too. Proton centers are far fewer, the equipment is far larger and costlier, and insurance coverage varies by diagnosis. A radiation oncologist weighing photons against protons is usually asking a specific question: is there an organ behind this tumor that a stopping beam would meaningfully protect? When the answer is yes, protons earn their place. When it is no, a modern photon plan is often equivalent.

Brachytherapy: radiation from the inside out

Brachy comes from the Greek for short, and short distance is the point. Instead of sending radiation through several centimeters of healthy tissue to reach a tumor, brachytherapy places the radioactive source directly inside or immediately beside it. Radiation intensity falls off steeply with distance, so a source a few millimeters from the tumor delivers a high dose there while tissue a few centimeters away receives comparatively little.

The National Cancer Institute groups brachytherapy into three delivery styles. Interstitial brachytherapy places sources inside the tumor itself, as with seeds or temporary catheters in the prostate or breast. Intracavitary brachytherapy positions the source in a body cavity next to the tumor, the classic example being applicators placed in the vagina or uterus for cervical and endometrial cancers. Episcleral brachytherapy uses a small plaque attached to the eye for certain eye tumors.

Timing divides it further. Low-dose-rate treatment leaves sources in place for days or, with permanent seeds, indefinitely as they decay. High-dose-rate treatment threads a powerful source through catheters for minutes at a time, then removes it, often over a few outpatient sessions.

Where it is used: prostate, cervical, endometrial, breast, skin and some head and neck cancers, either alone or combined with external beam radiation. A permanent-seed patient carries a low level of radioactivity for weeks, and teams give straightforward precautions about close, prolonged contact with children and pregnant people during that time, as NCI guidance describes. Temporary high-dose-rate treatment leaves nothing behind.

Systemic radiation therapy: when the medicine itself is radioactive

The third broad type does not aim at a location at all. Systemic radiation therapy uses a radioactive substance that is swallowed or given through a vein, travels through the bloodstream, and concentrates in cancer cells because of their biology.

The oldest and best-known example uses a radioactive form of iodine. Thyroid cells, including most thyroid cancer cells, absorb iodine to make hormone; a radioactive version rides that same pathway and delivers its energy from within the cell. The National Cancer Institute lists this as standard care for certain thyroid cancers after surgery.

Newer approaches attach a radioactive atom to a molecule that seeks out a target on the cancer cell surface, an approach broadly called targeted radionuclide or radioligand therapy. Some bind receptors on neuroendocrine tumors; others target a protein common on advanced prostate cancer cells. Bone-seeking agents concentrate where cancer has spread to bone and is actively remodeling it. These treatments are given in specialist nuclear medicine settings, typically as a series of infusions spaced weeks apart, with decisions about eligibility and sequence made by the treating oncology team.

Because the radiation circulates, precautions differ from external beam therapy. For a period after each dose, the person’s body fluids are mildly radioactive, and guidance covers separate bathroom use, distance from others, and sleeping arrangements. Side effects reflect where the substance goes: bone marrow suppression, dry mouth from salivary uptake, or kidney exposure, depending on the agent. This is a rapidly evolving corner of oncology, and the Cleveland Clinic notes that clinical trials continue to define which tumors respond best.

Less common types you may hear about: intraoperative, total body and superficial

A few radiation techniques fall outside the three main categories in daily conversation, though technically each belongs to one.

Intraoperative radiation therapy delivers a single concentrated dose during surgery, after the tumor has been removed and before the incision is closed. With the surgeon holding healthy organs aside, the beam reaches the tumor bed directly. It is used in selected breast, pancreatic and some abdominal cancers, sometimes replacing or shortening a later course of external beam treatment, according to the Mayo Clinic.

Total body irradiation treats the entire body at a low intensity, most often as part of preparation for a stem cell or bone marrow transplant. The aim is to suppress the immune system and clear diseased marrow so donor cells can take hold. It is delivered over several sessions and is one of the few situations where radiation is deliberately not confined to a target.

Superficial and electron beam therapy treat skin and very shallow tumors. Electrons, unlike X-rays, penetrate only a short, predictable depth before stopping, which makes them suitable for skin cancers, scars prone to keloid formation, and tumors lying just beneath the surface. The National Cancer Institute includes electron beams among standard external beam options.

Hyperfractionated and hypofractionated schedules are not separate types but timing choices: more, smaller sessions, or fewer, larger ones. Over the past decade, guideline bodies have endorsed shorter hypofractionated courses for many breast and prostate cancers after large trials showed comparable outcomes, which has cut treatment time for many people from weeks to days.

Curative, adjuvant or palliative: when each type of radiation is used

The type of radiation matters less than the reason for giving it. Radiation oncologists sort every case into one of a few intents, and the intent drives the technique, the number of sessions and the acceptable side effects.

Treatment goal	What it means	Common technique choices	Typical schedule pattern
Curative (definitive)	Radiation is the main treatment intended to eliminate the cancer	IMRT, IGRT, brachytherapy, SBRT for small tumors	Daily weekday sessions over several weeks, or short stereotactic courses
Adjuvant	Given after surgery to destroy microscopic cells left behind	3D-conformal or IMRT to the surgical bed and nearby lymph nodes	Several weeks, increasingly shortened by hypofractionation
Neoadjuvant	Given before surgery to shrink a tumor and make removal easier	External beam, often with chemotherapy	Weeks, followed by a recovery gap before surgery
Palliative	Relieves pain, bleeding or pressure from advanced cancer	Simple external beam fields, single or few sessions	One to ten sessions
Conditioning	Prepares the body for a stem cell transplant	Total body irradiation	A few sessions over several days

Palliative radiation deserves more attention than it gets. The NHS notes that radiotherapy can ease symptoms even when cure is not the goal, and a single session to a painful bone metastasis often brings relief within days to weeks. Because the aim is comfort rather than eradication, planning is simpler and the schedule is deliberately brief.

Combining radiation with surgery or chemotherapy is routine. Chemotherapy given during a course of radiation can make cancer cells more sensitive to the beam, a strategy used in many head and neck, cervical, lung and rectal cancers. The sequencing decisions belong to a multidisciplinary tumor board, not to any single technique.

Which is harder on your body, chemotherapy or radiation?

People ask this constantly, and the honest answer is that they are hard in different ways because they work in different places.

Radiation is local. Its side effects appear almost entirely in and near the treated area, which is why the National Cancer Institute lists them by body region: skin redness and peeling where the beam enters, sore throat and taste changes with head and neck treatment, bowel and bladder irritation with pelvic treatment, hair loss only in the treated patch. Fatigue is the one effect that shows up regardless of site, and it tends to build over the course and resolve gradually in the weeks after.

Chemotherapy is systemic. Because it circulates, it reaches fast-dividing cells everywhere, which explains full-scalp hair loss, nausea, mouth sores, lowered blood counts and infection risk. Those effects usually come in waves tied to each cycle.

So a person having radiation to a small area of the leg may feel largely normal, while radiation to the throat can make eating painful for weeks. Someone on a mild chemotherapy regimen may work throughout; someone on an intensive one may need repeated hospital support. Comparing the two in the abstract does not help much.

What is useful to know: radiation side effects are largely predictable from the treatment map, so teams can tell you in advance which ones to expect. Most acute effects settle within weeks of the final session, according to NHS guidance. Late effects, which can appear months or years later, are the reason planning goes to such lengths to spare normal tissue and the reason follow-up continues long after treatment ends.

Can radiation therapy cause cancer, and which type is most likely to?

Yes, radiation therapy can cause a second cancer, and pretending otherwise would betray the evidence-first promise of this article. The same DNA damage that kills tumor cells can, rarely, produce a mutation in a surviving normal cell that decades later becomes malignant. The National Cancer Institute lists second cancers among the late side effects of radiation and describes them as uncommon.

Three factors shape the risk. Age at treatment matters most: children and young adults have more years ahead for a mutation to develop and more dividing tissue, which is why pediatric radiation planning is so conservative and why proton therapy has been adopted most enthusiastically there. Volume matters: treatments that expose large areas, such as historical wide-field techniques or total body irradiation, carry more risk than tightly conformal modern plans. Tissue type matters: breast, thyroid and bone marrow are among the more radiation-sensitive tissues.

As for which type of radiation is most likely to cause cancer, the question mixes two different things. Among therapeutic types, risk tracks exposure of healthy tissue rather than the modality name; a modern IMRT plan and a proton plan are both designed to minimize it. In everyday life, the CDC identifies radon gas in homes as the leading environmental source of radiation-related cancer, and the WHO notes that ionizing radiation of any kind, including medical imaging, carries a risk proportional to the amount received.

The balance that matters is stated plainly by every major cancer body: for someone with cancer, the immediate benefit of treating it far outweighs a small, delayed second-cancer risk. Reducing that risk further, through better beam shaping and shorter courses, is exactly what the past two decades of radiation technology have been about.

What is the newest radiation treatment for cancer, and does newer mean better?

Several technologies compete for the label of newest, and each deserves an honest appraisal rather than a headline.

Adaptive radiation therapy re-plans treatment during the course as a tumor shrinks or organs shift, rather than using a single plan made on day one. Newer machines combine a linear accelerator with an MRI scanner so soft tissue can be seen in real time on the table. The rationale is strong; the outcome data comparing it with standard IGRT are still accumulating.

Proton therapy, discussed above, is expanding, and carbon ion therapy, which uses heavier particles with an even sharper stopping point and stronger biological effect, is available at a small number of centers worldwide. Evidence for carbon ions in most cancers remains limited to early studies.

Targeted radionuclide therapies, the systemic agents that home in on specific cancer cell proteins, are arguably where the most significant recent shift has happened, with new agents entering routine use for advanced prostate and neuroendocrine cancers over the past several years.

FLASH radiotherapy, which delivers an entire treatment in a fraction of a second at extremely high rates, has shown intriguing normal-tissue sparing in laboratory studies. Human experience is limited to very early trials, and it should be regarded as experimental.

Does newer mean better? Sometimes, and the Cleveland Clinic and Mayo Clinic both frame advances mainly as ways to reduce side effects and shorten treatment. The technique with the best evidence for a given cancer is frequently a well-established one delivered expertly. A reasonable question to ask any team is not whether a machine is new, but what the published evidence shows for your specific diagnosis.

When to see a doctor during or after radiation therapy

Most side effects of radiation are expected, predictable and manageable, and the treatment team sees patients at least weekly during a course. Some signs, though, need prompt attention rather than a wait for the next scheduled visit.

Contact the treating team the same day, or seek emergency care, for a fever, especially if chemotherapy is being given alongside radiation and blood counts may be low; for skin in the treated area that has blistered, is weeping fluid or shows spreading redness and warmth, which can signal infection; for an inability to swallow liquids or keep fluids down for more than a day, since dehydration develops quickly; for chest pain, sudden breathlessness or coughing up blood; for new or worsening weakness or numbness in the arms or legs, or loss of bladder or bowel control, which can indicate pressure on the spinal cord; and for severe headache with vomiting or confusion after brain radiation. The NHS radiotherapy side-effects guidance advises reporting any symptom that is severe or unexpected without delay.

After treatment ends, follow-up matters for years, not weeks. Late effects can emerge slowly: stiffness or swelling in a treated limb, changes in bowel habit after pelvic radiation, thyroid underactivity after neck treatment, or heart and lung changes after chest radiation. Any of these deserves evaluation, and survivorship clinics exist precisely to catch them early.

One reassurance stands out in every major source. Someone who has had external beam radiation is not radioactive and poses no risk to others, and the specific precautions that apply after brachytherapy or systemic treatment are temporary and explained in detail by the care team before discharge.

Frequently asked questions

What is the most common type of radiation therapy?

External beam radiation therapy is the most common type. A machine called a linear accelerator directs high-energy X-rays at the tumor from outside the body, usually in short daily sessions on weekdays over several weeks. Modern versions such as IMRT and image-guided radiation shape and align the beam precisely. Nothing radioactive stays in the body, so the person is safe to be around others immediately after each session.

What is the newest radiation treatment for cancer?

Several technologies are new: MRI-guided adaptive radiation that re-plans treatment as the tumor changes, expanding proton and carbon ion centers, targeted radionuclide therapies that carry radiation to specific cancer cell proteins, and experimental FLASH radiotherapy delivered in under a second. Newer does not automatically mean better. For most cancers the strongest evidence still supports well-established techniques, and advances mainly reduce side effects and shorten courses.

Which is hardest on your body, chemo or radiation?

Neither is universally harder; they act in different places. Radiation is local, so side effects cluster in the treated area, plus fatigue. Chemotherapy circulates through the whole body, causing effects such as nausea, lowered blood counts and full hair loss. Radiation to a small area of the leg may cause little disruption, while radiation to the throat can make eating painful for weeks. The site and regimen decide the experience.

What type of radiation is most likely to cause cancer?

Among therapeutic types, the risk of a second cancer tracks how much healthy tissue is exposed and the age of the patient, not the name of the technique. Older wide-field methods and total body irradiation carry more risk than tightly shaped modern plans. In everyday life, the CDC identifies radon gas in homes as the leading environmental source of radiation-related cancer. Any ionizing radiation carries risk proportional to the amount received.

Is proton therapy better than regular radiation?

Proton therapy is better at one specific thing: stopping at a set depth so tissue behind the tumor receives little radiation. That makes it valuable for children and for tumors in front of critical structures like the brainstem or heart. For many common adult cancers, comparative trials have not consistently shown better outcomes than a well-planned photon IMRT course. The choice depends on anatomy, and a modern photon plan is often equivalent.

How long does a course of radiation therapy take?

It depends on the goal. The Mayo Clinic describes individual sessions as generally lasting about 10 to 30 minutes, most of it positioning. Curative external beam courses commonly run on weekdays for several weeks, though many breast and prostate schedules are now shorter. Stereotactic treatments finish in one to a few sessions, and palliative radiation for pain may be a single visit. The team sets the schedule based on tumor type and intent.

What is brachytherapy and when is it used?

Brachytherapy is internal radiation: sealed radioactive sources are placed inside or right next to the tumor, either permanently as small seeds or temporarily through thin tubes for minutes at a time. Because radiation weakens sharply with distance, the tumor receives a high dose while nearby organs receive far less. It is standard for many cervical, endometrial and prostate cancers, and is also used for breast, skin and eye tumors.

Does radiation therapy hurt?

The treatment itself is painless; there is no sensation while the beam is on, similar to having an X-ray. Discomfort comes later from the tissue response and depends on the area treated. Skin in the beam path may become red and sore over weeks, throat treatment can make swallowing painful, and pelvic treatment can irritate the bowel and bladder. These effects usually ease within weeks of the final session.

Are you radioactive after radiation therapy?

After external beam radiation, no. The beam passes through the body and leaves nothing behind, so there is no risk to family, children or pregnant people. After permanent brachytherapy seeds or systemic radioactive treatments, a low level of radioactivity is present for a limited time, and the care team gives specific, temporary precautions about close contact and hygiene. Temporary high-dose-rate brachytherapy leaves nothing radioactive in the body.

What is stereotactic body radiation therapy (SBRT)?

SBRT delivers a large amount of radiation to a small, precisely located tumor in one to a handful of sessions instead of many weeks. It relies on rigid positioning, dozens of converging beam angles and imaging immediately before treatment, sometimes tracking breathing motion. It is used for early lung cancers in people who cannot have surgery, liver and spine tumors, and limited sites of spread. It is not suitable for large or diffuse tumors.

References

• NHS: Radiotherapy
• Cleveland Clinic: Radiation Therapy

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.